RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT

NCT ID: NCT01885299

Last Updated: 2024-09-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

50000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-03-31

Study Completion Date

2030-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The RSSearch® Registry is an international multi-year database designed to track SRS/SBRT (Stereotactic Radiosurgery/Stereotactic Body Radiation Therapy) utilization, treatment practices and outcomes to help determine, over time, the most effective use of these systems in management of patients with life threatening tumors and other diseases. (This study was formally called ReCKord and included the CyberKnife only; The ReCKord study continues as a CyberKnife subset of RSSearch.)

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The Registry is designed to help SRS/SBRT (Stereotactic Radiosurgery/Stereotactic Body Radiation Therapy) users to understand utilization of and key treatment outcomes for these treatment approaches. Some of the objectives include:

Allow participants to record information about usage of SRS/SBRT in everyday practice, including patient characteristics and disease information, treatment plans and outcomes Provide participants with ready access to data for publication of their own experience and as a tool for establishing collaborations with other participating sites Facilitate quality improvement efforts for individual treatment providers Understand the effectiveness of different treatment plans for different types of lesions, diseases and treatments

The Registry tracks select outcomes for each condition treated by SRS/SBRT (for example, PSA for prostate cancer); the Registry also provides individual participants the ability to add additional outcomes for each and any condition of specific interest to their institutions.

The Registry is hosted by Vision Tree, Inc who is an independent vendor of electronic registries; they are responsible for HIPAA compliance, including all security mechanisms.

Patients will be enrolled prospectively. Some retrospective patient data is likely to be included in order to capture both short and longer term outcomes data.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Neoplasms Arteriovenous Malformation of Central Nervous System Trigeminal Neuralgia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

OTHER

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients being treated by SRS/SBRT

Patients with a condition being considered for treatment by SRS/SBRT

SRS/SBRT

Intervention Type RADIATION

Intervention varies by condition being treated.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

SRS/SBRT

Intervention varies by condition being treated.

Intervention Type RADIATION

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosis of benign or malignant tumors or other conditions deemed treatable by stereotactic radiosurgery or stereotactic body radiotherapy
* Willingness to sign an Informed Consent Document or verbally agree to participation
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

VisionTree

UNKNOWN

Sponsor Role collaborator

The Radiosurgery Society

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Anand Mahadevan, MD

Role: STUDY_DIRECTOR

The Radiosurgery Society

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Penrose Cancer Center

Colorado Springs, Colorado, United States

Site Status ENROLLING_BY_INVITATION

Sylvester Comprehensive Cancer Center, University of Miami

Miami, Florida, United States

Site Status RECRUITING

Southeast Georgia Health System

Brunswick, Georgia, United States

Site Status ENROLLING_BY_INVITATION

Henry Ford Health System

Detroit, Michigan, United States

Site Status RECRUITING

AtlantiCare Regional Medical Center and AtlantiCare Cancer Care Institute

Egg Harbor, New Jersey, United States

Site Status ENROLLING_BY_INVITATION

Riverview Medical Center

Red Bank, New Jersey, United States

Site Status ENROLLING_BY_INVITATION

NJ Cyberknife at Community Medical Center

Toms River, New Jersey, United States

Site Status ENROLLING_BY_INVITATION

Montefiore Medical Center

The Bronx, New York, United States

Site Status ENROLLING_BY_INVITATION

Geisinger Health System

Danville, Pennsylvania, United States

Site Status ENROLLING_BY_INVITATION

Philadelphia CyberKnife

Philadelphia, Pennsylvania, United States

Site Status ENROLLING_BY_INVITATION

Pottstown Memorial Medical Center

Pottstown, Pennsylvania, United States

Site Status ENROLLING_BY_INVITATION

Cyberknife at Erlanger

Chattanooga, Tennessee, United States

Site Status ENROLLING_BY_INVITATION

St. Mary's Medical Center

Huntington, West Virginia, United States

Site Status ENROLLING_BY_INVITATION

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jan Jenkins, RN

Role: CONTACT

Joanne Davis, PHD

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Gregory A Azzam, MD

Role: primary

Celina Kirsch, P.A.

Role: primary

313-640-2345

References

Explore related publications, articles, or registry entries linked to this study.

Tipton KN, Sullivan N, Bruening W, Inamdar R, Launders J, Uhl S, Schoelles KM. Stereotactic Body Radiation Therapy [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2011 May. Report No.: 10(11)-EHC058-EF. Available from http://www.ncbi.nlm.nih.gov/books/NBK55723/

Reference Type BACKGROUND
PMID: 21735562 (View on PubMed)

Dieterich S, Gibbs IC. The CyberKnife in clinical use: current roles, future expectations. Front Radiat Ther Oncol. 2011;43:181-194. doi: 10.1159/000322423. Epub 2011 May 20.

Reference Type BACKGROUND
PMID: 21625154 (View on PubMed)

Wowra B, Muacevic A, Tonn JC. CyberKnife radiosurgery for brain metastases. Prog Neurol Surg. 2012;25:201-9. doi: 10.1159/000331193. Epub 2012 Jan 6.

Reference Type BACKGROUND
PMID: 22236681 (View on PubMed)

Sarwate D, Sarkar S, Krimsky WS, Burgan CM, Patel K, Evans R, Harley DP. Optimization of mediastinal staging in potential candidates for stereotactic radiosurgery of the chest. J Thorac Cardiovasc Surg. 2012 Jul;144(1):81-6. doi: 10.1016/j.jtcvs.2012.03.004. Epub 2012 Apr 11.

Reference Type BACKGROUND
PMID: 22498085 (View on PubMed)

Sohn S, Chung CK. The role of stereotactic radiosurgery in metastasis to the spine. J Korean Neurosurg Soc. 2012 Jan;51(1):1-7. doi: 10.3340/jkns.2012.51.1.1. Epub 2012 Jan 31.

Reference Type BACKGROUND
PMID: 22396835 (View on PubMed)

Davis JN, Medbery C, Sharma S, Pablo J, Kimsey F, Perry D, Muacevic A, Mahadevan A. Stereotactic body radiotherapy for centrally located early-stage non-small cell lung cancer or lung metastases from the RSSearch((R)) patient registry. Radiat Oncol. 2015 May 15;10:113. doi: 10.1186/s13014-015-0417-5.

Reference Type BACKGROUND
PMID: 25975848 (View on PubMed)

Davis JN, Medbery C 3rd, Sharma S, Perry D, Pablo J, D'Ambrosio DJ, McKellar H, Kimsey FC, Chomiak PN, Mahadevan A. Stereotactic body radiotherapy for early-stage non-small cell lung cancer: clinical outcomes from a National Patient Registry. J Radiat Oncol. 2015;4(1):55-63. doi: 10.1007/s13566-014-0177-0. Epub 2015 Jan 31.

Reference Type BACKGROUND
PMID: 25774243 (View on PubMed)

Davis JN, Medbery C 3rd, Sharma S, Danish A, Mahadevan A. The RSSearch Registry: patterns of care and outcomes research on patients treated with stereotactic radiosurgery and stereotactic body radiotherapy. Radiat Oncol. 2013 Nov 25;8:275. doi: 10.1186/1748-717X-8-275.

Reference Type BACKGROUND
PMID: 24274599 (View on PubMed)

Ricco A, Davis J, Rate W, Yang J, Perry D, Pablo J, D'Ambrosio D, Sharma S, Sundararaman S, Kolker J, Creach KM, Lanciano R. Lung metastases treated with stereotactic body radiotherapy: the RSSearch(R) patient Registry's experience. Radiat Oncol. 2017 Feb 1;12(1):35. doi: 10.1186/s13014-017-0773-4.

Reference Type BACKGROUND
PMID: 28143558 (View on PubMed)

Davis J, Sharma S, Shumway R, Perry D, Bydder S, Simpson CK, D'Ambrosio D. Stereotactic Body Radiotherapy for Clinically Localized Prostate Cancer: Toxicity and Biochemical Disease-Free Outcomes from a Multi-Institutional Patient Registry. Cureus. 2015 Dec 4;7(12):e395. doi: 10.7759/cureus.395.

Reference Type BACKGROUND
PMID: 26798571 (View on PubMed)

Singh R, Davis J, Sharma S. Stereotactic Radiosurgery for Trigeminal Neuralgia: A Retrospective Multi-Institutional Examination of Treatment Outcomes. Cureus. 2016 Apr 3;8(4):e554. doi: 10.7759/cureus.554.

Reference Type BACKGROUND
PMID: 27182468 (View on PubMed)

Mahadevan A, Blanck O, Lanciano R, Peddada A, Sundararaman S, D'Ambrosio D, Sharma S, Perry D, Kolker J, Davis J. Stereotactic Body Radiotherapy (SBRT) for liver metastasis - clinical outcomes from the international multi-institutional RSSearch(R) Patient Registry. Radiat Oncol. 2018 Feb 13;13(1):26. doi: 10.1186/s13014-018-0969-2.

Reference Type DERIVED
PMID: 29439707 (View on PubMed)

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Informed Consent Form

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RSSearch Patient Registry

Identifier Type: -

Identifier Source: org_study_id

NCT01563549

Identifier Type: -

Identifier Source: nct_alias

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Preop fSRS for Resectable Brain Metastases
NCT05267587 ACTIVE_NOT_RECRUITING PHASE2